Prurigo Nodularis Clinical Trials

Intense Itching with Prurigo Nodularis? Right now, doctors at Medical Center for Clinical Research in San Diego are conducting a new research study for chronic itch with prurigo nodularis (PN). The study is for an investigational medication that may help reduce uncomfortable itching associated with PN.

This is a double-blind, randomized, placebo-controlled study to assess the efficacy, safety, and tolerability of serlopitant for the treatment of pruritus (itching) in adults with prurigo nodularis (abbreviated as PN, a skin condition with multiple very itchy, solid skin bumps that develop due to scratching).  All enrolled subjects will receive ...

The PRISM Study is for adults 18 years of age and older who have been diagnosed with Prurigo Nodularis. The purpose of this study, is to test the safety and effectiveness of an investigational study drug for Pruritus (“Itch”) Relief.

Chronic itch associated with Prurigo Nodularis

This is a research study of an investigational drug called serlopitant, which is being tested for the treatment of pruritus in people with prurigo nodularis (abbreviated as PN, a skin condition with multiple very itchy, solid skin bumps that develop due to scratching).  Pruritus, also called itch, is defined as ...

A research study is evaluating an investigational medication for Prurigo Nodularis (PN), a condition characterized by intensely itchy nodules on the skin. Those with PN often find that scratching does not relieve the itch.

We are searching for individuals to participate in a clinical trial testing the safety and efficacy of an investigational drug when used for the treatment of PN itch.  

The purpose of the PRISM Study, is to test the safety and effectiveness of an investigational study drug fro Pruritus ("Itch") Relief.  

This study is testing the efficacy and safety of an oral medication in patients with Prurigo Nodularis for pruritis (severe itch) relief.  

Prurigo nodularis(PN) is a chronic skin disease, characterized by severe pruritus, multiple hyperkeratotic nodules and papules often located on the extensor part of the upper and lower extremities with a symmetrical distribution. The disease often appears between 20-60 years of age affecting men and women equally. The pathogenesis of PN ...